Thrombosis Research
Volume 121, Issue 2 , Pages 203-212 , 2007

VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: Involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases

  • David Ratel

      Affiliations

    • Laboratoire de Médecine Moléculaire Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Hôpital Ste-Justine et Université du Québec à Montréal, 3175 Chemin Côte-Ste-Catherine, Montréal, Qc, Canada H3T 1C5
    • Present address: INSERM U318, UJFG, CHU Michallon, 38043 Grenoble, France.
    • ,
  • Samira Mihoubi

      Affiliations

    • Laboratoire de Médecine Moléculaire Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Hôpital Ste-Justine et Université du Québec à Montréal, 3175 Chemin Côte-Ste-Catherine, Montréal, Qc, Canada H3T 1C5
    • ,
  • Edith Beaulieu

      Affiliations

    • Laboratoire de Médecine Moléculaire Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Hôpital Ste-Justine et Université du Québec à Montréal, 3175 Chemin Côte-Ste-Catherine, Montréal, Qc, Canada H3T 1C5
    • ,
  • Yves Durocher

      Affiliations

    • Animal Cell Technology Group, Biotechnology Research Institute, National Research Council Canada, 6100 Royalmount Avenue, Montréal, Québec, Canada H4P2R2
    • ,
  • Georges-Etienne Rivard

      Affiliations

    • Service d'Hématologie-Oncologie, Hôpital Ste-Justine, Montréal, Québec, Canada H3T 1C5
    • ,
  • Denis Gingras

      Affiliations

    • Laboratoire de Médecine Moléculaire Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Hôpital Ste-Justine et Université du Québec à Montréal, 3175 Chemin Côte-Ste-Catherine, Montréal, Qc, Canada H3T 1C5
    • Corresponding Author InformationCorresponding authors. Laboratoire de médecine moléculaire, Centre de recherche de l'Hôpital Ste-Justine, 3175 Chemin Côte-Ste-Catherine, Montréal, QC, Canada H3T 1C5. Tel.: +1 514 345 2366; fax: +1 514 345 2359.
    • ,
  • Richard Béliveau

      Affiliations

    • Laboratoire de Médecine Moléculaire Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Hôpital Ste-Justine et Université du Québec à Montréal, 3175 Chemin Côte-Ste-Catherine, Montréal, Qc, Canada H3T 1C5
    • Service d'Hématologie-Oncologie, Hôpital Ste-Justine, Montréal, Québec, Canada H3T 1C5
    • Corresponding Author InformationCorresponding authors. Laboratoire de médecine moléculaire, Centre de recherche de l'Hôpital Ste-Justine, 3175 Chemin Côte-Ste-Catherine, Montréal, QC, Canada H3T 1C5. Tel.: +1 514 345 2366; fax: +1 514 345 2359.

Received 10 November 2006 ,Revised 2 March 2007 ,Accepted 28 March 2007.

References 

  1. Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001;106:148–156
  2. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE. 2001;2001:RE21
  3. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029–1039
  4. Vailhe B, Ronot X, Tracqui P, Usson Y, Tranqui L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim. 1997;33:763–773
  5. Nash GF, Walsh DC, Kakkar AK. The role of the coagulation system in tumour angiogenesis. Lancet Oncol. 2001;2:608–613
  6. Wojtukiewicz MZ, Sierko E, Klement P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3:371–384
  7. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res. 2001;102:V215–V224
  8. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104–1117
  9. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991;78:3114–3124
  10. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci. 2000;57:25–40
  11. Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol. 1996;132:1177–1188
  12. Kroon ME, Koolwijk P, van Goor H, Weidle UH, Collen A, van der Pluijm G, et al. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol. 1999;154:1731–1742
  13. Mimura K, Sueishi K, Yasunaga C, Tanaka K. Fibrinolysis activity promotes tumor invasiveness of B16 melanoma cell lines through a reconstituted gel matrix. Invasion Metastasis. 1992;12:24–34
  14. Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, et al. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. Cancer Res. 1999;59:1327–1336
  15. Diaz VM, Planaguma J, Thomson TM, Reventos J, Paciucci R. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology. 2002;122:806–819
  16. Carmeliet P, Bouche A, De Clercq C, Janssen S, Pollefeyt S, Wyns S, et al. Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice. Ann N Y Acad Sci. 1995;748:367–381[discussion 381–362]
  17. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysis. Cell. 1998;95:365–377
  18. Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, et al. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med. 2002;195:295–308
  19. Lafleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci. 2002;115:3427–3438
  20. Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, et al. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood. 2003;101:1810–1817
  21. Pedersen JA, Swartz MA. Mechanobiology in the third dimension. Ann Biomed Eng. 2005;33:1469–1490
  22. Schindler M, Nur EKA, Ahmed I, Kamal J, Liu HY, Amor N, et al. Living in three dimensions: 3D nanostructured environments for cell culture and regenerative medicine. Cell Biochem Biophys. 2006;45:215–227
  23. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, et al. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem. 2004;279:52132–52140
  24. Gingras D, Nyalendo C, Di Tomasso G, Annabi B, Beliveau R. Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent. Biochem Biophys Res Commun. 2004;320:205–212
  25. Shibuya M. Vascular endothelial growth factor (VEGF)-receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium. 2006;13:63–69
  26. De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med. 2002;12:241–246
  27. Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000;60:2178–2189
  28. Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood. 2004;103:955–962
  29. Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev. 1983;2:41–73
  30. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 1991;181:902
  31. Buser R, Montesano R, Garcia I, Dupraz P, Pepper MS. Bovine microvascular endothelial cells immortalized with human telomerase. J Cell Biochem. 2006;98:267–286
  32. Rijken DC, Sakharov DV. Basic principles in thrombolysis: regulatory role of plasminogen. Thromb Res. 2001;103(Suppl 1):S41–S49
  33. Engelse MA, Hanemaaijer R, Koolwijk P, van Hinsbergh VW. The fibrinolytic system and matrix metalloproteinases in angiogenesis and tumor progression. Semin Thromb Hemost. 2004;30:71–82
  34. Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel–Palade bodies in bovine microvascular endothelial cells. Thromb Haemost. 2001;86:702–709
  35. Matsushita K, Yamakuchi M, Morrell CN, Ozaki M, O'Rourke B, Irani K, et al. Vascular endothelial growth factor regulation of Weibel–Palade-body exocytosis. Blood. 2005;105:207–214
  36. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel–Palade body exocytosis. Trends Cardiovasc Med. 2005;15:302
  37. Matsushita K, Morrell CN, Lowenstein CJ. Sphingosine 1-phosphate activates Weibel–Palade body exocytosis. PNAS. 2004;101:11483–11487
  38. Stack MS, Gately S, Bafetti LM, Enghild JJ, Soff GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J. 1999;340(Pt 1):77–84

☆ This work was supported by a grant from the Canadian Institutes for Health Research to D.G. and R.B.

PII: S0049-3848(07)00126-0

doi: 10.1016/j.thromres.2007.03.024

Thrombosis Research
Volume 121, Issue 2 , Pages 203-212 , 2007

Article Tools

* Image Usage & Resolution